Bio Farmag is working to develop a world-first innovative test for the detection of breast cancer using hair. The breakthrough technology that underpins the Bio Farmag™ Test is the discovery by an Australian scientist that breast cancer can potentially be detected by synchrotron x-ray diffraction of hair. The test is non-invasive and suitable for women from as early as 20 years of age. It may provide early detection of breast cancer thus assist in early treatment. Early detection benefits range from increased survival, increased treatment options and improved quality of life. The Bio Farmag™ Test is in trial and not yet available commercially.
This shareholder information section enables you to access your unit holding information by completing the form in the attached link. If you wish to change your details please find the contact information for the Share Registry, Link Market Services.
To access your unit holding please click here
If you wish to change your details please click here
